Ameliorative effects and mechanism of crocetin in arsenic trioxide-induced cardiotoxicity in rats

Arsenic trioxide (ATO) is commonly used to treat patients with acute promyelocytic leukemia since it was authorized by the U.S. Food and Drug Administration in the 1970s, but its applicability has been limited by its cardiotoxic effects. Therefore, the aim of the present study was to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhifeng, Li, Jinghan, Zheng, Bin, Liang, Yingran, Shi, Jing, Zhang, Jianping, Han, Xue, Chu, Li, Chu, Xi, Gao, Yonggang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646993/
https://www.ncbi.nlm.nih.gov/pubmed/33173984
http://dx.doi.org/10.3892/mmr.2020.11587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646993/
https://www.ncbi.nlm.nih.gov/pubmed/33173984
http://dx.doi.org/10.3892/mmr.2020.11587

Ejemplares similares